Dr. Brett Heintz received his bachelor of science in cell and molecular biology at San Diego State University in 2001 and his doctorate in pharmacy from the University of California, San Francisco in 2005. He completed his residencies in pharmacy practice and infectious diseases at the University of California, Davis Medical Center in Sacramento, CA. He also is a board certified pharmacotherapy specialist with added qualifications in infectious diseases and American Academy of HIV expert certified.
Dr. Heintz, a Pharmacy Specialist in Internal Medicine and Infectious Diseases, joined the Iowa City VA Health Care System in September 2012. He also holds an academic position as Clinical Associate Professor at the University of Iowa College of Pharmacy and precepts pharmacy students, delivers didactic lectures and coordinates a pharmacotherapy course. Prior to joining the Iowa City VA and the University of Iowa he served as an Assistant Professor of Clinical Pharmacy at UC San Francisco School of Pharmacy with a clinical practice in Infectious Diseases and Internal Medicine at UC Davis Medical Center.
Dr. Heintz’s primary research and clinical interests include antimicrobial dosing in special populations, including renal failure, dialysis, hepatic failure and obesity and management of outpatient delivery of antimicrobial therapy.
Dr. Heintz has authored several articles and book chapters related to antimicrobial therapy and has presented at local, state, national, and international level meetings. He is also the recipient of several teaching awards.
Dr. Brett Heintz's primary research platform is focused on the evaluation of appropriate antimicrobial use, antimicrobial dosing in special populations (renal failure, renal replacement therapy and obesity), applied antimicrobial pharmacokinetics and pharmacodynamics, outcome and economic assessment of outpatient delivery of antimicrobial therapy, impact of antimicrobial stewardship and the effect of formulary management on antimicrobial resistance trends and outcomes, and determination of predictors of resistance, treatment failure and toxicity of antistaphylococcal and antipseudomonal agents.
Dr. Brett Heintz joined the Iowa City VA Health Care System (ICVAHCS) in September 2012. At the ICVAHCS he maintains a high-level internal medicine / infectious disease clinical pharmacy practice, including evaluation of patients, providing therapeutic interventions, rounds with providers, collaborates with consult services, order/adjust medications and labs per protocol, precepts University of Iowa college of pharmacy students and ICVAHCS pharmacy residents, serves on various college of pharmacy and institutional committees, and delivers educational and other academic responsibilities. In addition, he serves as the antimicrobial stewardship pharmacy program director and provides assistance with outpatient parenteral antibiotic therapy (OPAT). In his previous position at UC Davis Medical Center and the UC, San Francisco School of Pharmacy he served as member of the adult/pediatric antimicrobial stewardship programs, provided clinical services on the internal medicine and infectious disease services, and co-coordinated an OPAT service.